Therefore, the study by Shvefel and colleagues is consistent with studies that have demonstrated MIF to be a driver of immune evasion, tumor aggressiveness, and poor clinical outcomes in animal models, as well as in retrospective patient clinical data [9]. Here, MIF is linked to neoplasm.